Eurasian Union For Medtech Gathers Pace, But Barriers Hamper Timely Completion
Executive Summary
The transition deadline for adoption of Eurasian Economic Union (EAEU) medtech principles across the five member states remains the end of 2021, but vital elements are still not resolved, giving rise, for the first time, to notions of a delay in adoption. This would be the pragmatic course, local market experts believe, but for now, efforts are aimed at completing the system on time.
You may also be interested in...
QMS And Lab Accreditations Allow Russian Regulator To Green Light Eurasian Device System
Harmonization of medical device regulation in the five member-state Eurasian Economic Union has advanced considerably in recent months – on the sticky issue of Quality Management Systems (QMS) and on the readiness of Russian labs to sign up to the system. There is no turning back now that the system has been declared user-ready.
EAEU Medtech Agreement Will Have Upsides, But Manufacturers Must Plan Well
It might seem that the Eurasian Economic Union (EAEU) agreement on medical device regulation is nothing but administrative issues and slow progress, but it should deliver benefits to all stakeholders after launch, currently slated for 2022. but manufacturers need to be mindful of the member states' strengths and weaknesses when selecting their reference member state.
Russian Medtech Industry Wants Quicker Progress On Eurasian Bloc Plans – 2017 Now Targeted
The much-anticipated Eurasian Economic Union (EAEU) was originally targeted to come into effect at the start of 2016, but more than year later, the five-member trading bloc has yet to be ratified by all nations. The Russian medtech industry is impatient for progress, but IMEDA's Sergey Kolosov sees some promising signs in recent developments.